StonvexLoading…
StonvexStonvexStonvexCore line items from STIM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $149.16M | $74.89M | $71.35M | $65.21M |
Operating Income | $-31.44M | $-34.56M | $-30.55M | $-35.11M |
Net Income | $-39.00M | $-43.71M | $-30.19M | $-37.16M |
EPS (Diluted) | $-0.59 | $-1.38 | $-1.05 | $-1.38 |
Total Assets | $141.55M | $140.90M | $115.83M | $116.88M |
Total Liabilities | $115.31M | $109.10M | $81.64M | $59.82M |
Cash & Equivalents | $28.13M | $18.46M | $59.68M | $70.34M |
Free Cash Flow OCF − CapEx | $-21.18M | $-32.46M | $-34.41M | $-34.01M |
Shares Outstanding | 68.99M | 55.68M | 29.09M | 27.27M |